-- 長春ハイテク工業（SHE:000661）の子会社である長春遺伝子科製薬は、GenSci155注射剤の臨床試験申請について、中国の規制当局の承認を取得した。 深セン証券取引所への木曜日の提出書類によると、この薬剤は早産児の気管支肺異形成症の予防および急性虚血性脳卒中の治療に適応される。
Related Articles
International
OECD Says New Zealand Should Stop Frequent Changes to RBNZ Mandate
The Organisation for Economic Cooperation and Development (OECD) said New Zealand should reconsider how frequently it adjusts the Reserve Bank of New Zealand's remit, as frequent changes raise the risk of monetary policy mistakes, according to a Thursday report published by the organization.The central bank's remit is set by New Zealand's Minister of Finance and covers its operational objectives, including the target inflation range.The OECD said there have been frequent changes to the monetary policy mandate and remit since 2019, and that maintaining stability outside scheduled five-year review cycles would support the bank's credibility and enhance its ability to deliver on its inflation objectives.The organization recommended reinforcing the RBNZ's operational independence and credibility, noting that maintaining stability for the full five-year cycle until the 2028 review would support predictability, credibility, and confidence in the monetary policy regime.
$^NZ50
Asia
CITIC Securities Unit Issues $5 Million in Bonds
CITIC Securities (SHA:600030, HKG:6030) indirect unit CSI MTN issued $5 million in medium term notes.Proceeds will be used to supplement working capital, according to a Wednesday filing with the Shanghai bourse.Shares of the financial services provider were down 1% in recent trade on the Shanghai bourse and 2% on the Hong Kong bourse.
$HKG:6030$SHA:600030
Equities
Harbour Energy's Q1 Production, Revenue Grows
Harbour Energy (HBR.L) said Thursday that its production and revenue increased year over year in the three months ended March 31.The oil and gas company's production was 506,000 barrels of oil equivalent per day, compared with 500,000 boepd previously. Meanwhile, revenue increased to $3 billion from $2.8 billion.Looking ahead, the company upgraded its production guidance to 480,000 boepd to 500,000 boepd, compared with a previous range of 475,000 boepd to 500,000 boepd.
$HBR.L